Provectus Pharmaceuticals' Reverse Merger Round

Provectus Pharmaceuticals raised a round of funding on April 23, 2002.

Provectus Pharmaceuticals (OTCQB: PVCT) is a clinical-stage biopharmaceutical company developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. Provectus' investigat…

Articles about Provectus Pharmaceuticals' Reverse Merger Round: